Physician profile
Deepak Kumar Singh
NPI 1861703555
$520.81
in general payments reported to CMS, 2019-2025
10 companies · $40.15 in 2025
The $40.15 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $170 · 2021: $89.41 · 2022: $36.41 · 2023: $43.05 · 2025: $40.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $83.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $83.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $154.68 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $119.11 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $54.96 | 2020-2021 | |
| Abbott Laboratories | $43.05 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Ucb, INC. | $42.71 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $35.85 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $25.04 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.70 | 2020 | |
| Boston Scientific Corporation | $15.53 | 2022 | |
| Csl Behring | $12.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.